Clinical manifestations and risk factors of shock in children with multisystem inflammatory syndrome
Background: Multisystem inflammatory syndrome in children (MIS-C) is a novel disease associated with COVID-19. The COVID-19 epidemic peaked in May 2022 in Taiwan, and we encountered our first case of MIS-C in late May 2022. We aimed to present patients’ clinical manifestations and identify risk fact...
Main Authors: | Chi-Hsien Wu, Tu-Hsuan Chang, Boon-Fatt Tan, Jong-Lin Wu, Song-Ming Huang, Ting-Yu Yen, En-Ting Wu, Ching-Chia Wang, Min-Tai Lin, Chun-Yi Lu, Luan-Yin Chang, Li-Min Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664623004035 |
Similar Items
-
New insight into the intravenous immunoglobulin treatment in Multisystem Inflammatory Syndrome in children and adults
by: Chih-Jen Chen, et al.
Published: (2024-01-01) -
Marked elevation of procalcitonin level can lead to a misdiagnosis of anaphylactic shock as septic shock
by: Young Jun Kim, et al.
Published: (2015-08-01) -
Analysis of cardiac manifestation and treatment of multisystem inflammatory syndrome in children related to SARS-CoV-2
by: Stasa Krasic, et al.
Published: (2023-03-01) -
Effectiveness of COVID-19 vaccination against multisystem inflammatory syndrome in children: A systematic review and meta-analysis
by: Ting-Hui Liu, et al.
Published: (2023-12-01) -
The Multifaceted Manifestations of Multisystem Inflammatory Syndrome during the SARS-CoV-2 Pandemic
by: Héctor Raúl Pérez-Gómez, et al.
Published: (2022-05-01)